Clinical Trial Update: Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy of an SNRI for generalized anxiety disorder and comorbid conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Snippet

Sponsor: START Clinic for Mood and Anxiety Disorders | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED